Researchers have discovered two blood biomarkers that could predict cognitive deficits, including “brain fog,” up to a year after a COVID-19 diagnosis. The study analyzed data from over 1,800 hospitalized patients and identified high levels of fibrinogen and d-dimer, proteins linked to blood coagulation, as being highly correlated with cognitive issues.